Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Needle-Free Peptide Delivery Market Research Report 2026
Global Needle-Free Peptide Delivery Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-03-12
Pages: 134 Pages
Report ld: 6234729
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Needle-Free Peptide Delivery Market Size(US$)
CAGR 2026-2032
8.4%
Market Size,2032
USD 599
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 369 million
Market Forecast in 2032(Value)
US$ 599 million
CAGR
8.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Needle-Free Peptide Delivery market was valued at US$ 343 million in 2025 and is anticipated to reach US$ 599 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Needle-Free Peptide Delivery is a technology system that efficiently delivers peptide drugs to target sites in the body in a non-invasive or minimally invasive manner without the use of traditional injection needles. Its core goal is to solve the problems of pain, fear, infection risk and low patient compliance caused by traditional injection, while ensuring that peptide drugs (usually with large molecular weight, strong hydrophilicity, and easy to be degraded by enzymes) can break through physiological barriers such as skin and mucous membranes to achieve effective absorption and exert pharmacological effects.
The North American market for Needle-Free Peptide Delivery is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Needle-Free Peptide Delivery is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Needle-Free Peptide Delivery in Hospitals & Clinics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Needle-Free Peptide Delivery include Zynerba Pharmaceuticals, Portal Instruments, Crossject Société Anonyme, 3M, Antares Pharma, Zogenix, PharmaJet, Inovio Pharmaceuticals, Bioject Medical Technologies, Valeritas, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Needle-Free Peptide Delivery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Needle-Free Peptide Delivery. The Needle-Free Peptide Delivery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Needle-Free Peptide Delivery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Needle-Free Peptide Delivery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Zynerba Pharmaceuticals
- Portal Instruments
- Crossject Société Anonyme
- 3M
- Antares Pharma
- Zogenix
- PharmaJet
- Inovio Pharmaceuticals
- Bioject Medical Technologies
- Valeritas
- Takeda Pharmaceutical Company
- Medical International Technology
- Endo International
- Akra Dermojet
- TheraJect
- TARI Labs
- InsuJet
- Gerresheimer AG
- Mitsubishi Tanabe Pharma Corporation
- Novartis AG
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Jet Injectors
- Inhaler Technology
- Transdermal Patch Technology
- Electroporation
- Laser-Powered Systems
- Microporation
Segment by Application
- Hospitals & Clinics
- Home Care
- Research Laboratories
- Pharmaceutical & Biotech Companies
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Needle-Free Peptide Delivery companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Needle-Free Peptide Delivery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Jet Injectors
1.2.3 Inhaler Technology
1.2.4 Transdermal Patch Technology
1.2.5 Electroporation
1.2.6 Laser-Powered Systems
1.2.7 Microporation
1.3 Market by Application
1.3.1 Global Needle-Free Peptide Delivery Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Home Care
1.3.4 Research Laboratories
1.3.5 Pharmaceutical & Biotech Companies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Needle-Free Peptide Delivery Market Perspective (2021–2032)
2.2 Global Needle-Free Peptide Delivery Growth Trends by Region
2.2.1 Global Needle-Free Peptide Delivery Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Needle-Free Peptide Delivery Historic Market Size by Region (2021–2026)
2.2.3 Needle-Free Peptide Delivery Forecasted Market Size by Region (2027–2032)
2.3 Needle-Free Peptide Delivery Market Dynamics
2.3.1 Needle-Free Peptide Delivery Industry Trends
2.3.2 Needle-Free Peptide Delivery Market Drivers
2.3.3 Needle-Free Peptide Delivery Market Challenges
2.3.4 Needle-Free Peptide Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Needle-Free Peptide Delivery Players by Revenue
3.1.1 Global Top Needle-Free Peptide Delivery Players by Revenue (2021–2026)
3.1.2 Global Needle-Free Peptide Delivery Revenue Market Share by Players (2021–2026)
3.2 Global Top Needle-Free Peptide Delivery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Needle-Free Peptide Delivery Revenue
3.4 Global Needle-Free Peptide Delivery Market Concentration Ratio
3.4.1 Global Needle-Free Peptide Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Needle-Free Peptide Delivery Revenue in 2025
3.5 Global Key Players of Needle-Free Peptide Delivery Head Offices and Areas Served
3.6 Global Key Players of Needle-Free Peptide Delivery, Products and Applications
3.7 Global Key Players of Needle-Free Peptide Delivery, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Needle-Free Peptide Delivery Breakdown Data by Type
4.1 Global Needle-Free Peptide Delivery Historic Market Size by Type (2021–2026)
4.2 Global Needle-Free Peptide Delivery Forecasted Market Size by Type (2027–2032)
5 Needle-Free Peptide Delivery Breakdown Data by Application
5.1 Global Needle-Free Peptide Delivery Historic Market Size by Application (2021–2026)
5.2 Global Needle-Free Peptide Delivery Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Needle-Free Peptide Delivery Market Size (2021–2032)
6.2 North America Needle-Free Peptide Delivery Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Needle-Free Peptide Delivery Market Size by Country (2021–2026)
6.4 North America Needle-Free Peptide Delivery Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Needle-Free Peptide Delivery Market Size (2021–2032)
7.2 Europe Needle-Free Peptide Delivery Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Needle-Free Peptide Delivery Market Size by Country (2021–2026)
7.4 Europe Needle-Free Peptide Delivery Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Needle-Free Peptide Delivery Market Size (2021–2032)
8.2 Asia-Pacific Needle-Free Peptide Delivery Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2021–2026)
8.4 Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Needle-Free Peptide Delivery Market Size (2021–2032)
9.2 Latin America Needle-Free Peptide Delivery Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Needle-Free Peptide Delivery Market Size by Country (2021–2026)
9.4 Latin America Needle-Free Peptide Delivery Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Needle-Free Peptide Delivery Market Size (2021–2032)
10.2 Middle East & Africa Needle-Free Peptide Delivery Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2021–2026)
10.4 Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Details
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals Needle-Free Peptide Delivery Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 Portal Instruments
11.2.1 Portal Instruments Company Details
11.2.2 Portal Instruments Business Overview
11.2.3 Portal Instruments Needle-Free Peptide Delivery Introduction
11.2.4 Portal Instruments Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.2.5 Portal Instruments Recent Development
11.3 Crossject Société Anonyme
11.3.1 Crossject Société Anonyme Company Details
11.3.2 Crossject Société Anonyme Business Overview
11.3.3 Crossject Société Anonyme Needle-Free Peptide Delivery Introduction
11.3.4 Crossject Société Anonyme Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.3.5 Crossject Société Anonyme Recent Development
11.4 3M
11.4.1 3M Company Details
11.4.2 3M Business Overview
11.4.3 3M Needle-Free Peptide Delivery Introduction
11.4.4 3M Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.4.5 3M Recent Development
11.5 Antares Pharma
11.5.1 Antares Pharma Company Details
11.5.2 Antares Pharma Business Overview
11.5.3 Antares Pharma Needle-Free Peptide Delivery Introduction
11.5.4 Antares Pharma Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.5.5 Antares Pharma Recent Development
11.6 Zogenix
11.6.1 Zogenix Company Details
11.6.2 Zogenix Business Overview
11.6.3 Zogenix Needle-Free Peptide Delivery Introduction
11.6.4 Zogenix Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.6.5 Zogenix Recent Development
11.7 PharmaJet
11.7.1 PharmaJet Company Details
11.7.2 PharmaJet Business Overview
11.7.3 PharmaJet Needle-Free Peptide Delivery Introduction
11.7.4 PharmaJet Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.7.5 PharmaJet Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Details
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Needle-Free Peptide Delivery Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Details
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Needle-Free Peptide Delivery Introduction
11.9.4 Bioject Medical Technologies Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.9.5 Bioject Medical Technologies Recent Development
11.10 Valeritas
11.10.1 Valeritas Company Details
11.10.2 Valeritas Business Overview
11.10.3 Valeritas Needle-Free Peptide Delivery Introduction
11.10.4 Valeritas Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.10.5 Valeritas Recent Development
11.11 Takeda Pharmaceutical Company
11.11.1 Takeda Pharmaceutical Company Company Details
11.11.2 Takeda Pharmaceutical Company Business Overview
11.11.3 Takeda Pharmaceutical Company Needle-Free Peptide Delivery Introduction
11.11.4 Takeda Pharmaceutical Company Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.11.5 Takeda Pharmaceutical Company Recent Development
11.12 Medical International Technology
11.12.1 Medical International Technology Company Details
11.12.2 Medical International Technology Business Overview
11.12.3 Medical International Technology Needle-Free Peptide Delivery Introduction
11.12.4 Medical International Technology Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.12.5 Medical International Technology Recent Development
11.13 Endo International
11.13.1 Endo International Company Details
11.13.2 Endo International Business Overview
11.13.3 Endo International Needle-Free Peptide Delivery Introduction
11.13.4 Endo International Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.13.5 Endo International Recent Development
11.14 Akra Dermojet
11.14.1 Akra Dermojet Company Details
11.14.2 Akra Dermojet Business Overview
11.14.3 Akra Dermojet Needle-Free Peptide Delivery Introduction
11.14.4 Akra Dermojet Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.14.5 Akra Dermojet Recent Development
11.15 TheraJect
11.15.1 TheraJect Company Details
11.15.2 TheraJect Business Overview
11.15.3 TheraJect Needle-Free Peptide Delivery Introduction
11.15.4 TheraJect Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.15.5 TheraJect Recent Development
11.16 TARI Labs
11.16.1 TARI Labs Company Details
11.16.2 TARI Labs Business Overview
11.16.3 TARI Labs Needle-Free Peptide Delivery Introduction
11.16.4 TARI Labs Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.16.5 TARI Labs Recent Development
11.17 InsuJet
11.17.1 InsuJet Company Details
11.17.2 InsuJet Business Overview
11.17.3 InsuJet Needle-Free Peptide Delivery Introduction
11.17.4 InsuJet Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.17.5 InsuJet Recent Development
11.18 Gerresheimer AG
11.18.1 Gerresheimer AG Company Details
11.18.2 Gerresheimer AG Business Overview
11.18.3 Gerresheimer AG Needle-Free Peptide Delivery Introduction
11.18.4 Gerresheimer AG Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.18.5 Gerresheimer AG Recent Development
11.19 Mitsubishi Tanabe Pharma Corporation
11.19.1 Mitsubishi Tanabe Pharma Corporation Company Details
11.19.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.19.3 Mitsubishi Tanabe Pharma Corporation Needle-Free Peptide Delivery Introduction
11.19.4 Mitsubishi Tanabe Pharma Corporation Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.19.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.20 Novartis AG
11.20.1 Novartis AG Company Details
11.20.2 Novartis AG Business Overview
11.20.3 Novartis AG Needle-Free Peptide Delivery Introduction
11.20.4 Novartis AG Revenue in Needle-Free Peptide Delivery Business (2021–2026)
11.20.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Needle-Free Peptide Delivery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Jet Injectors
Table 3. Key Players of Inhaler Technology
Table 4. Key Players of Transdermal Patch Technology
Table 5. Key Players of Electroporation
Table 6. Key Players of Laser-Powered Systems
Table 7. Key Players of Microporation
Table 8. Global Needle-Free Peptide Delivery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Needle-Free Peptide Delivery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Needle-Free Peptide Delivery Market Size by Region (US$ Million), 2021–2026
Table 11. Global Needle-Free Peptide Delivery Market Share by Region (2021–2026)
Table 12. Global Needle-Free Peptide Delivery Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Needle-Free Peptide Delivery Market Share by Region (2027–2032)
Table 14. Needle-Free Peptide Delivery Market Trends
Table 15. Needle-Free Peptide Delivery Market Drivers
Table 16. Needle-Free Peptide Delivery Market Challenges
Table 17. Needle-Free Peptide Delivery Market Restraints
Table 18. Global Needle-Free Peptide Delivery Revenue by Players (US$ Million), 2021–2026
Table 19. Global Needle-Free Peptide Delivery Market Share by Players (2021–2026)
Table 20. Global Top Needle-Free Peptide Delivery Players by Tier (Tier 1, Tier 2, and Tier 3), based on Needle-Free Peptide Delivery Revenue, 2025
Table 21. Ranking of Global Top Needle-Free Peptide Delivery Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Needle-Free Peptide Delivery Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Needle-Free Peptide Delivery, Headquarters and Area Served
Table 24. Global Key Players of Needle-Free Peptide Delivery, Products and Applications
Table 25. Global Key Players of Needle-Free Peptide Delivery, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Needle-Free Peptide Delivery Market Size by Type (US$ Million), 2021–2026
Table 28. Global Needle-Free Peptide Delivery Revenue Market Share by Type (2021–2026)
Table 29. Global Needle-Free Peptide Delivery Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Needle-Free Peptide Delivery Revenue Market Share by Type (2027–2032)
Table 31. Global Needle-Free Peptide Delivery Market Size by Application (US$ Million), 2021–2026
Table 32. Global Needle-Free Peptide Delivery Revenue Market Share by Application (2021–2026)
Table 33. Global Needle-Free Peptide Delivery Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Needle-Free Peptide Delivery Revenue Market Share by Application (2027–2032)
Table 35. North America Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2021–2026
Table 37. North America Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Needle-Free Peptide Delivery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (US$ Million), 2027–2032
Table 50. Zynerba Pharmaceuticals Company Details
Table 51. Zynerba Pharmaceuticals Business Overview
Table 52. Zynerba Pharmaceuticals Needle-Free Peptide Delivery Product
Table 53. Zynerba Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 54. Zynerba Pharmaceuticals Recent Development
Table 55. Portal Instruments Company Details
Table 56. Portal Instruments Business Overview
Table 57. Portal Instruments Needle-Free Peptide Delivery Product
Table 58. Portal Instruments Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 59. Portal Instruments Recent Development
Table 60. Crossject Société Anonyme Company Details
Table 61. Crossject Société Anonyme Business Overview
Table 62. Crossject Société Anonyme Needle-Free Peptide Delivery Product
Table 63. Crossject Société Anonyme Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 64. Crossject Société Anonyme Recent Development
Table 65. 3M Company Details
Table 66. 3M Business Overview
Table 67. 3M Needle-Free Peptide Delivery Product
Table 68. 3M Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 69. 3M Recent Development
Table 70. Antares Pharma Company Details
Table 71. Antares Pharma Business Overview
Table 72. Antares Pharma Needle-Free Peptide Delivery Product
Table 73. Antares Pharma Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 74. Antares Pharma Recent Development
Table 75. Zogenix Company Details
Table 76. Zogenix Business Overview
Table 77. Zogenix Needle-Free Peptide Delivery Product
Table 78. Zogenix Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 79. Zogenix Recent Development
Table 80. PharmaJet Company Details
Table 81. PharmaJet Business Overview
Table 82. PharmaJet Needle-Free Peptide Delivery Product
Table 83. PharmaJet Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 84. PharmaJet Recent Development
Table 85. Inovio Pharmaceuticals Company Details
Table 86. Inovio Pharmaceuticals Business Overview
Table 87. Inovio Pharmaceuticals Needle-Free Peptide Delivery Product
Table 88. Inovio Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 89. Inovio Pharmaceuticals Recent Development
Table 90. Bioject Medical Technologies Company Details
Table 91. Bioject Medical Technologies Business Overview
Table 92. Bioject Medical Technologies Needle-Free Peptide Delivery Product
Table 93. Bioject Medical Technologies Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 94. Bioject Medical Technologies Recent Development
Table 95. Valeritas Company Details
Table 96. Valeritas Business Overview
Table 97. Valeritas Needle-Free Peptide Delivery Product
Table 98. Valeritas Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 99. Valeritas Recent Development
Table 100. Takeda Pharmaceutical Company Company Details
Table 101. Takeda Pharmaceutical Company Business Overview
Table 102. Takeda Pharmaceutical Company Needle-Free Peptide Delivery Product
Table 103. Takeda Pharmaceutical Company Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 104. Takeda Pharmaceutical Company Recent Development
Table 105. Medical International Technology Company Details
Table 106. Medical International Technology Business Overview
Table 107. Medical International Technology Needle-Free Peptide Delivery Product
Table 108. Medical International Technology Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 109. Medical International Technology Recent Development
Table 110. Endo International Company Details
Table 111. Endo International Business Overview
Table 112. Endo International Needle-Free Peptide Delivery Product
Table 113. Endo International Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 114. Endo International Recent Development
Table 115. Akra Dermojet Company Details
Table 116. Akra Dermojet Business Overview
Table 117. Akra Dermojet Needle-Free Peptide Delivery Product
Table 118. Akra Dermojet Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 119. Akra Dermojet Recent Development
Table 120. TheraJect Company Details
Table 121. TheraJect Business Overview
Table 122. TheraJect Needle-Free Peptide Delivery Product
Table 123. TheraJect Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 124. TheraJect Recent Development
Table 125. TARI Labs Company Details
Table 126. TARI Labs Business Overview
Table 127. TARI Labs Needle-Free Peptide Delivery Product
Table 128. TARI Labs Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 129. TARI Labs Recent Development
Table 130. InsuJet Company Details
Table 131. InsuJet Business Overview
Table 132. InsuJet Needle-Free Peptide Delivery Product
Table 133. InsuJet Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 134. InsuJet Recent Development
Table 135. Gerresheimer AG Company Details
Table 136. Gerresheimer AG Business Overview
Table 137. Gerresheimer AG Needle-Free Peptide Delivery Product
Table 138. Gerresheimer AG Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 139. Gerresheimer AG Recent Development
Table 140. Mitsubishi Tanabe Pharma Corporation Company Details
Table 141. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 142. Mitsubishi Tanabe Pharma Corporation Needle-Free Peptide Delivery Product
Table 143. Mitsubishi Tanabe Pharma Corporation Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 144. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 145. Novartis AG Company Details
Table 146. Novartis AG Business Overview
Table 147. Novartis AG Needle-Free Peptide Delivery Product
Table 148. Novartis AG Revenue in Needle-Free Peptide Delivery Business (US$ Million), 2021–2026
Table 149. Novartis AG Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Needle-Free Peptide Delivery Picture
Figure 2. Global Needle-Free Peptide Delivery Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Needle-Free Peptide Delivery Market Share by Type: 2025 vs 2032
Figure 4. Jet Injectors Features
Figure 5. Inhaler Technology Features
Figure 6. Transdermal Patch Technology Features
Figure 7. Electroporation Features
Figure 8. Laser-Powered Systems Features
Figure 9. Microporation Features
Figure 10. Global Needle-Free Peptide Delivery Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Needle-Free Peptide Delivery Market Share by Application: 2025 vs 2032
Figure 12. Hospitals & Clinics Case Studies
Figure 13. Home Care Case Studies
Figure 14. Research Laboratories Case Studies
Figure 15. Pharmaceutical & Biotech Companies Case Studies
Figure 16. Others Case Studies
Figure 17. Needle-Free Peptide Delivery Report Years Considered
Figure 18. Global Needle-Free Peptide Delivery Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Needle-Free Peptide Delivery Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Needle-Free Peptide Delivery Market Share by Region: 2025 vs 2032
Figure 21. Global Needle-Free Peptide Delivery Market Share by Players in 2025
Figure 22. Global Needle-Free Peptide Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Needle-Free Peptide Delivery Revenue in 2025
Figure 24. North America Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Needle-Free Peptide Delivery Market Share by Country (2021–2032)
Figure 26. United States Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Needle-Free Peptide Delivery Market Share by Country (2021–2032)
Figure 30. Germany Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Needle-Free Peptide Delivery Market Share by Region (2021–2032)
Figure 38. China Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Needle-Free Peptide Delivery Market Share by Country (2021–2032)
Figure 46. Mexico Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Needle-Free Peptide Delivery Market Share by Country (2021–2032)
Figure 50. Israel Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Needle-Free Peptide Delivery Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Zynerba Pharmaceuticals Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 54. Portal Instruments Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 55. Crossject Société Anonyme Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 56. 3M Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 57. Antares Pharma Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 58. Zogenix Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 59. PharmaJet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 60. Inovio Pharmaceuticals Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 61. Bioject Medical Technologies Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 62. Valeritas Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 63. Takeda Pharmaceutical Company Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 64. Medical International Technology Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 65. Endo International Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 66. Akra Dermojet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 67. TheraJect Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 68. TARI Labs Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 69. InsuJet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 70. Gerresheimer AG Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 71. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 72. Novartis AG Revenue Growth Rate in Needle-Free Peptide Delivery Business (2021–2026)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 8.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Needle-Free Peptide Delivery market size from 2026 to 2032?
What was the global market size of Needle-Free Peptide Delivery in 2026?
What was the global market size of Needle-Free Peptide Delivery in 2032?
Which companies rank high in the global Needle-Free Peptide Delivery market?
Related Reports
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Needle-Free Peptide Delivery market is projected to grow from US$ 343 million in 2025 to US$ 599 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 153
USD 4900.00
(Single User License)
Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Needle-Free Peptide Delivery market size was US$ 343 million in 2025 and is forecast to reach a readjusted size of US$ 599 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 108
USD 4250.00
(Single User License)
Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 343 million in 2025 and is projected to reach US$ 599 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 132
USD 3950.00
(Single User License)
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Needle-Free Peptide Delivery market is projected to grow from US$ 296 million in 2024 to US$ 557 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 154
USD 4900.00
(Single User License)
Global Needle-Free Peptide Delivery Market Research Report 2025
The global market for Needle-Free Peptide Delivery was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 557 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published Date: 2025-07-31
Pages: 91
USD 2900.00
(Single User License)
Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-07-31
Pages: 130
USD 3950.00
(Single User License)
Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Needle-Free Peptide Delivery market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-07-31
Pages: 101
USD 4250.00
(Single User License)
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Needle-Free Peptide Delivery market is projected to grow from US$ 343 million in 2025 to US$ 599 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 153
USD 4900.00 (Single User License)Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Needle-Free Peptide Delivery market size was US$ 343 million in 2025 and is forecast to reach a readjusted size of US$ 599 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 108
USD 4250.00 (Single User License)Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 343 million in 2025 and is projected to reach US$ 599 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 132
USD 3950.00 (Single User License)Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Needle-Free Peptide Delivery market is projected to grow from US$ 296 million in 2024 to US$ 557 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 154
USD 4900.00 (Single User License)Global Needle-Free Peptide Delivery Market Research Report 2025
The global market for Needle-Free Peptide Delivery was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 557 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published: 2025-07-31
Pages: 91
USD 2900.00 (Single User License)Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-07-31
Pages: 130
USD 3950.00 (Single User License)Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Needle-Free Peptide Delivery market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-07-31
Pages: 101
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now